Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Dit Agtech Limited is a company patent portfolio with 1 pending office action. This matter is categorized within the Biotechnology & Pharmaceuticals technology area. The prosecution involves 1 distinct examiner, which indicates that the current workload is handled by a single individual. The data also shows that 1 distinct art unit is responsible for the review of this filing.
NGUYEN, JOHN P is identified as the busiest examiner for this portfolio, with 1 pending office action. This 1 pending action for the busiest examiner matches the total number of pending office actions for the company. The presence of 1 distinct art unit suggests that the technical evaluation is occurring within a specific department at the patent office. This focus allows for a prosecution strategy tailored to the standards of a single examination group.
With 1 distinct examiner and 1 distinct art unit, the prosecution environment for this Biotechnology & Pharmaceuticals portfolio is highly centralized. The single pending office action means that the company is not currently managing multiple simultaneous reviews. Practitioners can direct their communications to NGUYEN, JOHN P, who is the sole examiner listed for the 1 pending office action. This structure provides a clear and singular point of contact for the current portfolio activity.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NGUYEN, JOHN P | 1 | 43.9% | +41.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18282623 | A METHOD OF REDUCING METHANE PRODUCTION IN A RUMINANT ANIMAL | NGUYEN, JOHN P | — |
| Art Unit | Apps |
|---|---|
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18282623 | A METHOD OF REDUCING METHANE PRODUCTION IN A RUMINANT ANIMAL | NGUYEN, JOHN P | 1619 | §103 | Non-Final OA | — | Pending | Sep 18, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialDit Agtech Limited has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
John P Nguyen has the most, with 1 of Dit Agtech Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
